KYTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Kyverna Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$5.83+0.16 (+2.82%)
Close on Oct 19, 2026
- Market cap
- $355.03M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Kyverna Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 24, 2026 | Sep 24, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2026 | Jul 9, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 20, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 27, 2026 | Apr 13, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 17, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 19, 2025 | Sep 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | Jun 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2025 | Jan 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |